Posted by Web Team in
The independent regulator for health and social care in England has praised the positive impact of pharmacy professionals health and ...
Read morePosted by Web Team in
The CQC have released a report detailing their interim findings on the use of restrictive interventions in places that provide ...
Read morePosted by Speeds administrator in
Cariprazine The new antipsychotic cariprazine in now listed in BNF 77. Click here to view the BNF 77 Monograph for ...
Read morePosted by Web Team in
Monitoring the Mental Health Act is CQC's annual report on the use of the Mental Health Act (MHA). It looks ...
Read morePosted by Web Team in
From 1 April 2019, gabapentin and pregabalin will be reclassified as Schedule 3 controlled drugs under the Misuse of Drugs ...
Read more